Dr. John Swing, M.D

NPI: 1366493686
Total Payments
$63,541
2024 Payments
$5,429
Companies
21
Transactions
455
Medicare Patients
619
Medicare Billing
$55,637

Payment Breakdown by Category

Other$54,983 (86.5%)
Food & Beverage$6,046 (9.5%)
Travel$2,220 (3.5%)
Education$291.40 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $54,983 29 86.5%
Food and Beverage $6,046 406 9.5%
Travel and Lodging $2,220 12 3.5%
Education $291.40 8 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $31,582 84 $0 (2024)
Allergan, Inc. $27,358 103 $0 (2021)
Teva Pharmaceuticals USA, Inc. $648.06 22 $0 (2024)
Lundbeck LLC $568.24 37 $0 (2024)
Janssen Pharmaceuticals, Inc $517.24 29 $0 (2024)
Otsuka America Pharmaceutical, Inc. $514.42 34 $0 (2024)
Neurocrine Biosciences, Inc. $372.59 19 $0 (2024)
ITI, Inc. $338.72 22 $0 (2023)
Sunovion Pharmaceuticals Inc. $331.33 26 $0 (2021)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $290.24 24 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,429 62 ABBVIE INC. ($4,421)
2023 $15,806 62 AbbVie Inc. ($15,252)
2022 $7,867 17 ABBVIE INC. ($7,794)
2021 $8,063 74 AbbVie Inc. ($4,115)
2020 $7,902 32 Allergan, Inc. ($7,542)
2019 $17,001 91 Allergan Inc. ($16,352)
2018 $802.25 66 Allergan Inc. ($265.14)
2017 $669.87 51 Janssen Pharmaceuticals, Inc ($219.36)

All Payment Transactions

455 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
11/15/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $6.52 General
Category: PSYCHIATRY
11/13/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $103.54 General
Category: Neurology
11/13/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $16.12 General
Category: SCHIZOPHRENIA
11/08/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.18 General
Category: PSYCHIATRY
11/06/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $122.13 General
Category: Psychiatry/Psychology
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,125.00 General
Category: NEUROSCIENCE
10/29/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $6.24 General
Category: PSYCHIATRY
10/29/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $0.67 General
Category: PSYCHIATRY
10/23/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $16.07 General
Category: PSYCHIATRY
10/22/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $14.06 General
Category: PSYCHIATRY
10/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $35.50 General
Category: Neuropsychiatry
10/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $7.32 General
Category: PSYCHIATRY
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $31.47 General
Category: NEUROSCIENCE
10/16/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $15.11 General
Category: CNS
10/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $31.69 General
Category: Neuroscience
10/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $2.43 General
Category: NEUROSCIENCE
10/11/2024 Lundbeck LLC ABILIFY ASIMTUFII (Drug) Food and Beverage Cash or cash equivalent $17.16 General
Category: PSYCHIATRY
10/03/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $28.77 General
Category: PSYCHIATRY
09/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $7.53 General
Category: PSYCHIATRY
09/19/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $24.25 General
Category: Neurology
09/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.03 General
Category: NEUROSCIENCE
09/13/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $16.53 General
Category: PSYCHIATRY
09/06/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.71 General
Category: PSYCHIATRY
08/27/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,125.00 General
Category: NEUROSCIENCE
08/27/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.83 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 76 189 $12,285 $7,299
2022 1 104 232 $15,080 $8,231
2021 2 214 465 $32,745 $19,605
2020 2 225 498 $33,810 $20,501
Total Patients
619
Total Services
1,384
Medicare Billing
$55,637
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 76 189 $12,285 $7,299 59.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 104 232 $15,080 $8,231 54.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 172 409 $26,585 $15,900 59.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 42 56 $6,160 $3,706 60.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 196 466 $30,290 $18,123 59.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 29 32 $3,520 $2,378 67.5%

About Dr. John Swing, M.D

Dr. John Swing, M.D is a Psychiatry healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366493686.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Swing, M.D has received a total of $63,541 in payments from pharmaceutical and medical device companies, with $5,429 received in 2024. These payments were reported across 455 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,983).

As a Medicare-enrolled provider, Swing has provided services to 619 Medicare beneficiaries, totaling 1,384 services with total Medicare billing of $55,637. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Fredericksburg, VA
  • Active Since 05/12/2006
  • Last Updated 07/19/2011
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1366493686

Products in Payments

  • VRAYLAR (Drug) $58,930
  • CAPLYTA (Drug) $628.96
  • REXULTI (Drug) $531.89
  • ABILIFY MAINTENA (Drug) $372.96
  • INGREZZA (Drug) $372.59
  • LATUDA (Drug) $331.33
  • INVEGA SUSTENNA (Drug) $297.88
  • INVEGA TRINZA (Drug) $219.36
  • ARISTADA (Drug) $196.65
  • AUSTEDO (Drug) $173.82
  • VYVANSE (Drug) $163.51
  • UZEDY (Drug) $162.74
  • Austedo XR (Drug) $139.51
  • TRINTELLIX (Drug) $129.57
  • ABILIFY ASIMTUFII (Drug) $128.61
  • COBENFY (Drug) $122.13
  • Auvelity (Drug) $92.01
  • MYDAYIS (Drug) $74.35
  • QELBREE (Drug) $51.17
  • NUEDEXTA (Drug) $35.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Fredericksburg